An interventional study of Single Use Bronchoscope and Standard Bronchoscope in Atelectasis, Hemoptysis and Stridor, sponsored by Clinical Hospital Centre Zagreb. Completed at 1 site in Croatia. Open to participants aged 18 Years to 100 Years. Per ClinicalTrials.gov, last updated 2024-08-06.
Sponsored by Clinical Hospital Centre Zagreb · Not applicable, Interventional, and Treatment
Single Use Flexible bronchoscopes have gained popularity in recent years and are becoming technologically more advanced. They are widely accepted and used in everyday practice for simple procedures. The aim of this study is to evaluate single use flexible bronchoscopes in more advanced settings, such as interventional pulmonary procedures.
308 studies on the registry are indexed under Pulmonary Atelectasis; 79 are open to participants now.
This study's enrollment of 20 is below the median of 61 across 226 interventional studies indexed under Pulmonary Atelectasis.
Browse Pulmonary Atelectasis studies →Clinical Hospital Centre Zagreb is the lead sponsor of 32 studies on the registry; 9 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Device: Single Use Bronchoscope
Device: Standard Bronchoscope
The interventional procedure is performed with a single use bronchoscope.
The interventional procedure is performed with a standard bronchoscope.
Overall performance
Overall performance of the bronchoscope as graded by the operator (on a scale from 1 to 10; 1 worse, 10 best performance)
Time frame: through study completion, an average of 12 months
Functionality, handle and interface
Functionality, handle and interface of the bronchoscope as graded by the operator (on a scale from 1 to 10; 1 worse, 10 best performance)
Time frame: through study completion, an average of 12 months
Suction
Suction power of the bronchoscope as graded by the operator (on a scale from 1 to 10; 1 worse, 10 best performance)
Time frame: through study completion, an average of 12 months
Image quality
Image quality as graded by the operator (on a scale from 1 to 10; 1 worse, 10 best performance)
Time frame: through study completion, an average of 12 months
Bleeding control
Bleeding control as graded by the operator (on a scale from 1 to 10; 1 worse, 10 best performance)
Time frame: through study completion, an average of 12 months
Compatibility
Compatibility with other devices (i.e. ballon blockers, forceps, laser, cryprobe) as graded by the operator (on a scale from 1 to 10; 1 worse, 10 best performance)
Time frame: through study completion, an average of 12 months
This study is completed, as verified in Aug 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Clinical Hospital Centre Zagreb